Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Arrowhead Pharmaceuticals, Inc.
13D/A
Amendment 1
ARWR · 04280A100
|
0% |
8/15/2025
Event 8/13/2025
|
|||
| Sarepta Therapeutics, Inc. | 0% | ||||
| Sarepta Therapeutics Investments, Inc. | 0% | ||||
|
Arrowhead Pharmaceuticals, Inc.
13D
ARWR · 04280A100
|
9.5% |
2/14/2025
Event 2/7/2025
|
|||
| Sarepta Therapeutics, Inc. | 9.5% | ||||
| Sarepta Therapeutics Investments, Inc. | 9.5% | ||||